News from glaxosmithkline plc

Apr 30, 2014, 18:27 ET

GSK receives approval for Incruse™ Ellipta® (umeclidinium) in the US for the treatment of COPD

 GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Incruse™ Ellipta®...

Apr 28, 2014, 08:54 ET

Anoro™ Ellipta® now available in the US for treatment of COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that Anoro™ Ellipta® (umeclidinium and...

Apr 15, 2014, 14:26 ET

GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum™ (albiglutide)

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Tanzeum™ (albiglutide) for...

Dec 11, 2013, 17:55 ET

New England Journal of Medicine releases study showing GSK's FluLaval Quadrivalent vaccine effective in preventing seasonal flu in children

 GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that a peer-reviewed study issued online by the New England Journal of Medicine has...

Sep 18, 2013, 09:35 ET

GlaxoSmithKline, Community Care of North Carolina harness "small data" to improve patient care and reduce health care costs

 GlaxoSmithKline plc [LSE/NYSE: GSK] and Community Care of North Carolina (CCNC) today announced the initiation of a new approach to analyzing...

Apr 17, 2013, 17:18 ET

FDA Advisory Committee recommends approval of BREO™ ELLIPTA™ for the treatment of COPD

 GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the Pulmonary-Allergy Drugs Advisory Committee (PADAC)...

Dec 14, 2012, 17:41 ET

GSK receives FDA approval for raxibacumab anti-toxin for the treatment of inhalational anthrax

 GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the...

Dec 12, 2012, 09:00 ET

GlaxoSmithKline advances multi-city discussion focused on improving the health of US communities

 GlaxoSmithKline plc (LSE/NYSE: GSK) today proceeded with the next city stop in its national initiative to examine the barriers and identify...

Oct 24, 2012, 10:00 ET

GlaxoSmithKline Launches New Program to Help Consumers Recycle Empty GSK Respiratory Inhalers

GlaxoSmithKline plc (LSE/NYSE: GSK) has introduced a new program to help consumers recycle their empty GSK respiratory inhalers and keep waste out...

Jul 02, 2012, 10:50 ET

GlaxoSmithKline concludes previously announced agreement in principle to resolve multiple investigations with US Government and numerous states

 GlaxoSmithKline plc (GSK) today announced that it has reached an agreement with the US Government, multiple states and the District of...

Apr 26, 2012, 18:54 ET

FDA approves Votrient® for treatment of patients with certain types of advanced soft tissue sarcoma

 GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved Votrient® (pazopanib)...

Mar 31, 2011, 09:00 ET

GSK Publishes Payments for Research, Consulting and Advising by U.S. Healthcare Professionals

GlaxoSmithKline (NYSE: GSK) today published a list of payments made during 2010 for clinical research studies led by U.S. healthcare professionals....

Jul 01, 2010, 12:16 ET

GlaxoSmithKline and Genmab Announce Amendment to Ofatumumab Agreement

GlaxoSmithKline (NYSE and LSE: GSK) and Genmab A/S (OMX: GEN) announced today an amendment to the ofatumumab co-development and commercialisation...

Feb 01, 2010, 14:58 ET

GSK 2009 Financial Results Announcement and Teleconference Details

On Thursday, February 4, 2010, GlaxoSmithKline plc will announce its full year financial results for the year ended December 31, 2009.  It is...

Jul 22, 2009, 11:23 ET

GlaxoSmithKline Completes Acquisition of Stiefel

GlaxoSmithKline plc (GSK) (NYSE: GSK) today announced that it has completed its acquisition of Stiefel Laboratories, Inc. GSK has acquired...

Jul 16, 2009, 16:38 ET

GSK to Announce Q2 Results July 22, 2009

On Wednesday, July 22nd, GlaxoSmithKline plc (NYSE: GSK) will announce its second quarter financial results for the three months ended June 30,...

May 12, 2009, 08:23 ET

GSK Extends Strategic Collaboration with Aspen

- GSK to acquire 16% shareholding in Aspen in exchange for transfer of specialist products and manufacturing facility in Bad Oldesloe, Germany -...

May 06, 2009, 06:00 ET

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

GlaxoSmithKline plc (NYSE: GSK) today announced that it has entered into an agreement to divest full commercial rights to Wellbutrin XL(R) in the...

Apr 21, 2009, 13:22 ET

GSK Notice of First Quarter 2009 Financial Results Announcement and Teleconference

On Wednesday, April 22, 2009 GlaxoSmithKline plc (NYSE: GSK) will announce its first quarter financial results for the three months ended March 31,...

Apr 20, 2009, 07:00 ET

GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business

Stiefel, the world's largest independent dermatology company, acquired by GSK in deal valued at up to $3.6 billion New global business will have...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge